140.65
-1.90
(-1.33%)
At close: 5:36:16 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
4,408,000.00
3,784,000.00
4,259,000.00
4,616,000.00
3,477,000.00
Investing Cash Flow
-2,868,000.00
-1,892,000.00
-2,743,000.00
-1,578,000.00
-1,340,000.00
Financing Cash Flow
-713,000.00
-1,732,000.00
-1,555,000.00
-2,504,000.00
-1,522,000.00
End Cash Position
3,192,000.00
1,982,000.00
1,854,000.00
1,899,000.00
1,355,000.00
Capital Expenditure
-2,258,000.00
-2,023,000.00
-1,806,000.00
-1,421,000.00
-1,563,000.00
Issuance of Debt
1,202,000.00
1,216,000.00
2,918,000.00
859,000.00
6,437,000.00
Repayment of Debt
-1,821,000.00
-1,784,000.00
-3,506,000.00
-2,606,000.00
-7,272,000.00
Free Cash Flow
2,150,000.00
1,761,000.00
2,453,000.00
3,195,000.00
1,914,000.00
12/31/2020 - 6/26/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DMP.DE Dermapharm Holding SE
40.00
-0.12%
SDZ.SW Sandoz Group AG
38.65
-1.33%
29A.SG Amphastar Pharmaceuticals Inc
36.20
+3.08%
068760.KQ Celltrion Pharm, Inc.
56,300.00
-1.05%
H6D0.DE Haleon plc
4.4230
-0.94%
EVT.DE Evotec SE
8.06
-4.33%
0ET.MU Esperion Therapeutics Inc
2.1980
+2.66%
HIGH.DE Cantourage Group SE
4.8000
-0.41%
27N0.DE CANNOVUM CANNABIS AG I
0.5300
0.00%
B8FK.DE Biofrontera AG
2.5000
+10.13%